9amHealth

9amHealth provides virtual cardiometabolic care for weight management, diabetes and heart health. The program combines prescription medications when needed, personalized lifestyle plans, at-home lab tests, connected devices and access to specialists, delivered by a care team of obesity specialists, pharmacists, dietitians and behavioral health experts.

Its customers include employers and health plans that offer the program as a benefit to their members. The company has announced partnerships with Lilly, Novo Nordisk and Mark Cuban Cost Plus Drug Company to provide medication access through employer benefit plans, and a route for patients through the NovoCare website. The website does not state pricing details.

Co-founders listed on the website are Frank Westermann, Anton Kittelberger, Paul Geevarghese and Bernhard Schandl; the founding year is not stated. Investors named include Define Ventures, 7wireVentures, Cigna Ventures and SemperVirens. A $26M round was announced on May 13, 2026, bringing total funding to $55.6M. Open roles include clinical care, engineering, data, sales and customer success, with listed locations in Encinitas, CA and Vienna, Austria.

Product: Virtual cardiometabolic care program covering weight management, diabetes and heart health, with prescriptions, at-home labs and connected devices.